NEULANDLAB — Neuland Laboratories Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMid CapHigh Flyer

Annual balance sheet for Neuland Laboratories, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2021 March 31st	C2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IAS	IAS	IAS	IAS	IAS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	257	236	590	1,167	3,522
Net Total Accounts Receivable
Net Total Receivables	2,558	2,689	3,967	4,269	3,534
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	5,496	5,808	7,609	9,211	11,395
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	4,312	4,866	4,980	5,686	7,183
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	13,248	13,835	15,798	18,326	21,799
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	3,685	3,632	4,390	4,277	4,657
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Funded Status
Total Liabilities	5,383	5,430	5,857	5,499	6,551
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Unrealized Gain / Loss
Other Equity
Total Equity	7,865	8,405	9,941	12,827	15,248
Total Liabilities & Shareholders' Equity	13,248	13,835	15,798	18,326	21,799
Total Common Shares Outstanding